We are live on ! Find out more
William Blair & Company

William Blair & Company Portfolio holdings

AUM $34.9B
1-Year Est. Return 18.88%
This Fund
S&P 500
This Quarter Est. Return
+6.68%
1 Year Est. Return
+18.88%
3 Year Est. Return
+73.84%
5 Year Est. Return
+90.13%
10 Year Est. Return
+512.03%
AUM
$14.7B
AUM Growth
+$562M
Cap. Flow
-$182M
Cap. Flow %
-1.24%
Top 10 Hldgs %
20.54%
Holding
1,679
New
173
Increased
492
Reduced
677
Closed
92

Top Buys

Rank Stock Value
1
P
Everpure Inc
P
+$58.5M
2
DOCU
DocuSign
DOCU
+$21.3M
3
BKE icon
Buckle
BKE
+$20.9M
4
MSFT icon
Microsoft
MSFT
+$18.4M
5
USFD icon
US Foods
USFD
+$14.4M

Sector Composition

Rank Sector Weight
1 Technology 20.16%
2 Healthcare 17.99%
3 Financials 13.41%
4 Industrials 9.72%
5 Consumer Discretionary 9.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NTZ
1476
Natuzzi
NTZ
$14.2M
$25K ﹤0.01%
3,156
-1,200
-28% -$9.81K
EWS icon
1477
iShares MSCI Singapore ETF
EWS
$1.05B
$24K ﹤0.01%
1,020
+420
+70% +$11.1K
IBDQ
1478
DELISTED
iShares iBonds Dec 2025 Term Corporate ETF
IBDQ
$24K ﹤0.01%
1,000
ISCV icon
1479
iShares Morningstar Small-Cap Value ETF
ISCV
$701M
$24K ﹤0.01%
480
PZA icon
1480
Invesco National AMT-Free Municipal Bond ETF
PZA
$4.23B
$24K ﹤0.01%
966
SCHH icon
1481
Schwab US REIT ETF
SCHH
$11.5B
$24K ﹤0.01%
1,134
-152
-12% -$3.01K
GEF.B icon
1482
Greif Class B
GEF.B
$4.11B
$23K ﹤0.01%
400
TURN
1483
DELISTED
180 Degree Capital
TURN
$23K ﹤0.01%
+3,333
New +$21K
XPH icon
1484
State Street SPDR S&P Pharmaceuticals ETF
XPH
$491M
$23K ﹤0.01%
532
SLY
1485
DELISTED
SPDR S&P 600 Small Cap ETF (based on S&P SmallCap 600 Index--symbol SML)
SLY
$23K ﹤0.01%
320
AAXJ icon
1486
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.7B
$22K ﹤0.01%
307
+164
+115% +$12.5K
BOND icon
1487
PIMCO Active Bond Exchange-Traded Fund
BOND
$8.43B
$22K ﹤0.01%
210
FEMB icon
1488
First Trust Emerging Markets Local Currency Bond ETF
FEMB
$359M
$22K ﹤0.01%
580
PBE icon
1489
Invesco Biotechnology & Genome ETF
PBE
$284M
$22K ﹤0.01%
400
IHI icon
1490
iShares US Medical Devices ETF
IHI
$3.37B
$21K ﹤0.01%
630
-1,584
-72% -$51.6K
MOO icon
1491
VanEck Agribusiness ETF
MOO
$968M
$21K ﹤0.01%
330
ROM icon
1492
ProShares Ultra Technology
ROM
$1.16B
$21K ﹤0.01%
+1,600
New +$20.3K
SMLV icon
1493
State Street SPDR US Small Cap Low Volatility Index ETF
SMLV
$262M
$21K ﹤0.01%
224
SOCL icon
1494
Global X Social Media ETF
SOCL
$92.9M
$21K ﹤0.01%
+595
New +$20.8K
DIM icon
1495
WisdomTree International MidCap Dividend Fund
DIM
$167M
$20K ﹤0.01%
+303
New +$20.9K
RNDM
1496
DELISTED
First Trust Developed International Equity Select ETF
RNDM
$20K ﹤0.01%
400
TACOW
1497
DELISTED
Del Taco Restaurants, Inc. Warrants
TACOW
$20K ﹤0.01%
5,000
EWW icon
1498
iShares MSCI Mexico ETF
EWW
$1.97B
$19K ﹤0.01%
400
FXO icon
1499
First Trust Financials AlphaDEX Fund
FXO
$1.14B
$19K ﹤0.01%
600
IYT icon
1500
iShares US Transportation ETF
IYT
$2.26B
$19K ﹤0.01%
+400
New +$19.1K

Similar funds

William Blair & Company's Q2 2018 Portfolio in Review

As of Q2 2018, William Blair & Company held 1,679 positions worth $14.7B, up 4% from $14.1B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

William Blair & Company's Q2 2018 filing shows 173 new, 492 increased, 677 reduced and 92 closed positions. Its largest new stake was DocuSign: 422,114 shares worth $22.4M. The largest sale was Starbucks, an estimated $47M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.

  • William Blair & Company's largest Q2 2018 buy was DocuSign: 422,114 shares worth $22.4M.
  • William Blair & Company added most to Everpure Inc in Q2 2018, an estimated $58.5M increase.
  • William Blair & Company's biggest Q2 2018 reduction was Starbucks, cutting an estimated $47M.
  • William Blair & Company fully exited Cavium, Inc. in Q2 2018, selling an estimated $9.64M.
  • William Blair & Company's ten largest holdings make up 21% of its $14.7B portfolio in Q2 2018.
  • William Blair & Company opened 173 new positions and closed 92 in Q2 2018.
  • William Blair & Company's portfolio value rose 4% quarter-over-quarter to $14.7B.

Based on William Blair & Company's 13F filing for Q2 2018, filed 13 Aug 2018.